Literature DB >> 16888629

Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling.

Shih-Ching Lo1, Xuchu Li, Michael T Henzl, Lesa J Beamer, Mark Hannink.   

Abstract

Keap1 is a BTB-Kelch substrate adaptor protein that regulates steady-state levels of Nrf2, a bZIP transcription factor, in response to oxidative stress. We have determined the structure of the Kelch domain of Keap1 bound to a 16-mer peptide from Nrf2 containing a highly conserved DxETGE motif. The Nrf2 peptide contains two short antiparallel beta-strands connected by two overlapping type I beta-turns stabilized by the aspartate and threonine residues. The beta-turn region fits into a binding pocket on the top face of the Kelch domain and the glutamate residues form multiple hydrogen bonds with highly conserved residues in Keap1. Mutagenesis experiments confirmed the role of individual amino acids for binding of Nrf2 to Keap1 and for Keap1-mediated repression of Nrf2-dependent gene expression. Our results provide a detailed picture of how a BTB-Kelch substrate adaptor protein binds to its cognate substrate and will enable the rational design of novel chemopreventive agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888629      PMCID: PMC1538563          DOI: 10.1038/sj.emboj.7601243

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  62 in total

1.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model.

Authors:  A A Vaguine; J Richelle; S J Wodak
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-01-01

Review 2.  Pathways of oxidative damage.

Authors:  James A Imlay
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

3.  Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex.

Authors:  Donna D Zhang; Shih-Ching Lo; Janet V Cross; Dennis J Templeton; Mark Hannink
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription.

Authors:  Y Katoh; K Itoh; E Yoshida; M Miyagishi; A Fukamizu; M Yamamoto
Journal:  Genes Cells       Date:  2001-10       Impact factor: 1.891

Review 5.  Nrf2 as a target for cancer chemoprevention.

Authors:  Xiang Yu; Thomas Kensler
Journal:  Mutat Res       Date:  2005-07-28       Impact factor: 2.433

6.  BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase.

Authors:  Manabu Furukawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

7.  Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.

Authors:  David Bloom; Saravanakumar Dhakshinamoorthy; Anil K Jaiswal
Journal:  Oncogene       Date:  2002-03-28       Impact factor: 9.867

Review 8.  Glucose and reactive oxygen species.

Authors:  Dominique Bonnefont-Rousselot
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-09       Impact factor: 4.294

9.  Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron.

Authors:  Michael McMahon; Nerys Thomas; Ken Itoh; Masayuki Yamamoto; John D Hayes
Journal:  J Biol Chem       Date:  2004-05-13       Impact factor: 5.157

10.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

Authors:  Geng Wu; Guozhou Xu; Brenda A Schulman; Philip D Jeffrey; J Wade Harper; Nikola P Pavletich
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

View more
  162 in total

1.  TLR signaling prevents hyperoxia-induced lung injury by protecting the alveolar epithelium from oxidant-mediated death.

Authors:  Megan N Ballinger; Michael W Newstead; Xianying Zeng; Urvashi Bhan; Jeffrey C Horowitz; Bethany B Moore; David J Pinsky; Richard A Flavell; Theodore J Standiford
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.

Authors:  Ashish Jain; Trond Lamark; Eva Sjøttem; Kenneth Bowitz Larsen; Jane Atesoh Awuh; Aud Øvervatn; Michael McMahon; John D Hayes; Terje Johansen
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

3.  Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.

Authors:  Luisa M Solis; Carmen Behrens; Wenli Dong; Milind Suraokar; Natalie C Ozburn; Cesar A Moran; Alejandro H Corvalan; Shyam Biswal; Stephen G Swisher; B Nebiyou Bekele; John D Minna; David J Stewart; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2010-06-09       Impact factor: 12.531

4.  Molecular models and mutational analyses of plant specifier proteins suggest active site residues and reaction mechanism.

Authors:  Wolfgang Brandt; Anita Backenköhler; Eva Schulze; Antje Plock; Thomas Herberg; Elin Roese; Ute Wittstock
Journal:  Plant Mol Biol       Date:  2013-09-03       Impact factor: 4.076

5.  Genetic landscape of esophageal squamous cell carcinoma.

Authors:  Yi-Bo Gao; Zhao-Li Chen; Jia-Gen Li; Xue-Da Hu; Xue-Jiao Shi; Zeng-Miao Sun; Fan Zhang; Zi-Ran Zhao; Zi-Tong Li; Zi-Yuan Liu; Yu-Da Zhao; Jian Sun; Cheng-Cheng Zhou; Ran Yao; Su-Ya Wang; Pan Wang; Nan Sun; Bai-Hua Zhang; Jing-Si Dong; Yue Yu; Mei Luo; Xiao-Li Feng; Su-Sheng Shi; Fang Zhou; Feng-Wei Tan; Bin Qiu; Ning Li; Kang Shao; Li-Jian Zhang; Lan-Jun Zhang; Qi Xue; Shu-Geng Gao; Jie He
Journal:  Nat Genet       Date:  2014-08-24       Impact factor: 38.330

6.  Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.

Authors:  Bridgid E Hast; Erica W Cloer; Dennis Goldfarb; Heng Li; Priscila F Siesser; Feng Yan; Vonn Walter; Ning Zheng; D Neil Hayes; Michael B Major
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

7.  Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention.

Authors:  Murugesan Velayutham; Rajendra B Muthukumaran; Joe Z Sostaric; John McCraken; James C Fishbein; Jay L Zweier
Journal:  Free Radic Biol Med       Date:  2007-07-06       Impact factor: 7.376

8.  Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination.

Authors:  Bridgid E Hast; Dennis Goldfarb; Kathleen M Mulvaney; Michael A Hast; Priscila F Siesser; Feng Yan; D Neil Hayes; Michael B Major
Journal:  Cancer Res       Date:  2013-02-04       Impact factor: 12.701

Review 9.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

10.  Actin Cytoskeletal Organization in Drosophila Germline Ring Canals Depends on Kelch Function in a Cullin-RING E3 Ligase.

Authors:  Andrew M Hudson; Katelynn M Mannix; Lynn Cooley
Journal:  Genetics       Date:  2015-09-16       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.